Glybera Cures Untreatable Genetic Disorders



technology innovation, Glybera, future medical technology, lipoprotein lipase deficiency, LPLD, DNA, genetic disease, Europe, medical technology, future medicine
Has anybody of you ever thought of the fact, that even the simplest mutation or mis-coding in a gene may cause a serious problem? The innovative drug, Glybera, has been developed to treat a genetic disorder called lipoprotein lipase deficiency (LPLD). More than 1,000,000 people around the world suffer from this genetic disease, caused by a mutated gene that prevents people from making the enzymes necessary to properly metabolize fatty acids in their blood, leading to severe abdominal pain, diarrhea, and acute (and sometimes fatal) pancreatitis. Glybera goes in and modifies your DNA directly, using a deactivated virus to deliver new genetic code into cells, teaching them to properly produce the fat-metabolizing enzymes that they’ve been missing. This drug has been recently approved for use outside of a research hospital or clinical trial, so people will get a possibility to take it in 2013. Of course, Glybera will be very expensive: a series of one-time injections into a patient’s leg muscles will cost insurance companies in Europe $1.6 million per dose. Don’t forget, it’s a new generation of drugs that can treat diseases that were untreatable until now.
Via:dvice.com


More Posts:

THE MIZZOU Interactive Media Wall
Stephen Hawking - Rocket To The Future
Car That Runs On Air By Tata
Sustainable Europa City To Revive The North Of Paris
The Innovega Unveils Its New Eyewear System At CES 2013
Grow Organic Vegetables In The Indoor Nano Garden
Flying Drones Are Mapping New Oil Reserves In Norway
Mab - Finalist Electrolux Design Lab 2013
SkyWall: SkyWall100 Drone Defence System - A Man Portable and Cost Effective Counter Drone Syst...
DNA Data Storage Could Last Thousands Of Years